Short-term relugolix treatment for fibroid-related pain: where do we go from here?


Like Comment
Related Content

Volume 112, Issue 5, Pages 819–820


Paolo Vercellini, M.D.a,b, Giussy Barbara, M.D.a, Edgardo Somigliana, M.D.a,b


Reflections on "Relugolix. A novel oral GnRH antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo controlled, phase 3 study in Japanese women" by Osuga et al. 

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.